Saniya Ali is the chief technology officer and co-founder of Watershed Therapeutics, a pharmaceutical therapeutics company focused on solving large unmet clinical challenges in urology. Their current lead product shifts the paradigm in the treatment and prevention of recurrent urinary tract infections in women. Saniya leads and oversees operations and all aspects of research and product development. Prior to Watershed Therapeutics, she has worked as an innovator and scientist in the medical device and pharmaceutical industries with more than 10 years of experience in identifying unmet clinical needs and translating ideas into FDA-approved products that are used in clinics and surgery today. Saniya holds a Ph.D. in biomedical and biomaterials engineering from Duke and has completed post-doctoral training in medical innovation and biodesign at Stanford.